NEW YORK, April 2, 2024 /PRNewswire/ -- Gameto, a female-led biotechnology company with a mission to redefine women's healthcare, today announced encouraging new findings from a study evaluating how ...

Advances in biofabrication and 3D in vitro model systems are transforming biomedical research, drug development, and toxicity testing. However, despite ...

To identify the optimal in vitro maturation (IVM) duration for bovine oocytes with different nuclear maturation speeds (NMS), an Osaka Metropolitan University-led research team assessed how varying ...

Gameto, a biotechnology company, has raised $33 million in Series B funding, which it will use to support the clinical development of its in vitro maturation (IVM) product called Fertilo. New York ...

Manuscript demonstrates Gameto's manufacturing process resulted in ovarian support cells of improved efficacy, quality and safety for in vitro maturation applications NEW YORK, May 8, 2024 /PRNewswire ...

Researchers at Korea University applied magnetic torque stimulation to stem cell-derived cardiac organoids, activating ...